C12N 2710/16441
Use of virus, viral particle or viral elements as a vector
C12N2710/16441 (Use of virus, viral particle or viral elements as a vector) appears on 12 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 12
- Published applications
- 11
- Assignees
- 15
- Inventors
- 32
- Latest grant
- 19 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 2 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
- C12N 2710/16443Viral genome or elements thereof as genetic vectorIndexing code11
- C12N 2710/16442Virus or viral particle as vehicleIndexing code1
- C12N 2710/16444Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2710/16445Special targeting system for viral vectorsIndexing code0
Recent patents
- Compositions and methods for generating reversion free attenuated and/or replication incompetent vaccine vectors19 Oct 2021US 11,149,255 B2BioVentures, LLC
- Turkey herpesvirus vectored recombinant containing avian influenza genes19 May 2020US 10,655,146 B2Biomune Company
- Turkey herpesvirus vectored recombinant containing avian influenza genes11 Sep 2018US 10,072,272 B2Biomune Company
- Methods and compositions for transgene expression in a herpesvirus vector system3 Jul 2018US 10,010,594 B2President and Fellows of Harvard College
- Methods for the treatment of nonalcoholic steatohepatitis24 Nov 2015US 9,193,971 B2Institut National De La Sante Et De La Recherche Medicale (Inserm)
- Compositions and methods for generating reversion free attenuated and/or replication incompetent vaccine vectors11 Jul 2019US 2019/0211313 A1BioVentures, LLC
- Turkey herpesvirus vectored recombinant containing avian influenza genes20 Dec 2018US 2018/0363006 A1Biomune Company
- Turkey herpesvirus vectored recombinant containing avian influenza genes19 Oct 2017US 2017/0298386 A9Biomune Company
- Methods and compositions for transgene expression in a herpesvirus vector system15 Jun 2017US 2017/0165336 A1President and Fellows of Harvard College
- Turkey herpesvirus vectored recombinant containing avian influenza genes23 Apr 2015US 2015/0110835 A1Zeon Corporation
Most cited
By later US patents
- Herpesvirus saimiri as viral vector13US 6,379,967 B1University of Leeds · 2002
- Recombinant equine herpesviruses10US 5,741,696 ASyntro Corporation · 1998
- HIV vaccine7US 6,692,955 B1University of Leeds · 2004
- Equine herpesviruses (EHV) which contain foreign DNA, process for the preparation thereof and the use thereof in vaccines6US 6,187,320 B1Bayer Aktiengesellschaft · 2001
- Turkey herpesvirus vectored recombinant containing avian influenza genes3US 10,655,146 B2Biomune Company · 2020